Quince Therapeutics, Inc.
QNCX
$1.05
$0.05956.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -81.07% | -90.06% | -73.63% | 28.37% | 39.25% |
| Total Depreciation and Amortization | -42.24% | 690.00% | 288.00% | 88.52% | 57.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.67% | 145.97% | 147.97% | -51.18% | -37.42% |
| Change in Net Operating Assets | -124.48% | -5,222.50% | -749.59% | 90.07% | 120.11% |
| Cash from Operations | -74.42% | -68.60% | -40.45% | 26.78% | 58.46% |
| Capital Expenditure | -60.63% | 30.84% | 61.36% | 76.14% | -20.30% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -100.00% | 28.57% |
| Cash Acquisitions | -- | -- | -- | -119.98% | -119.98% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 720.52% | 144.63% | 415.97% | 43.06% | -147.81% |
| Cash from Investing | 480.48% | 118.56% | 362.21% | -123.54% | -131.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | 87.76% |
| Issuance of Common Stock | 51.01% | 206.52% | 204.17% | 48.95% | -80.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,439.16% | -7,038.24% | 450.94% | 109.63% | -79.77% |
| Foreign Exchange rate Adjustments | 188.75% | -183.92% | -104.63% | -31.34% | -56.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.98% | -86.27% | 39.20% | -19.43% | 5.24% |